English | 简体中文 | 繁體中文 | 한국어
 All Press Releases

Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT
雲頂新耀與海森生物簽署商業化服務協議及授權許可協議 推動商業化協同與多領域佈局
Dec 12, 2025 14:35 HKT
云顶新耀与海森生物签署商业化服务协议及授权许可协议 推动商业化协同与多领域布局
Dec 12, 2025 14:35 HKT
國泰海通成功發行非銀金融機構首單上海自貿離岸債
Dec 12, 2025 11:41 HKT
国泰海通成功发行非银金融机构首单上海自贸离岸债
Dec 12, 2025 11:41 HKT
紮根西藏 本土化團隊協同鑄就「礦業堡壘」!智匯礦業IPO背後的本土化競爭力
Dec 12, 2025 10:34 HKT
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 10:00 HKT
萬億工業賽道迎來「智慧樞紐」:解碼京東工業的價值邏輯
Dec 11, 2025 22:20 HKT
国泰君安国际荣登《商业周刊》彭博绿金2026值得关注榜 - 绿色金融机构榜单
Dec 11, 2025 22:10 HKT
國泰君安國際榮登《商業週刊》彭博綠金2026值得關注榜 - 綠色金融機構榜單
Dec 11, 2025 22:01 HKT
國泰君安國際蟬聯《信報財經新聞》上市公司卓越大獎
Dec 11, 2025 22:00 HKT
国泰君安国际蝉联《信报财经新闻》上市公司卓越大奖
Dec 11, 2025 22:00 HKT
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 21:00 HKT
康哲藥業(0867)抗急性缺血性卒中創新藥注射用Y-3中國NDA獲受理
Dec 11, 2025 20:01 HKT
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
Dec 11, 2025 20:00 HKT
康哲药业(0867)抗急性缺血性卒中创新药注射用Y-3中国NDA获受理
Dec 11, 2025 19:53 HKT
Eisai Rated "A", the Highest Rating by CDP in Both Climate Change and Water Security Categories for the Second Consecutive Year
Dec 11, 2025 18:41 HKT
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing
Dec 11, 2025 18:09 HKT
NEC Named to CDP's "A List" for Climate Change and Water Security for the Seventh Consecutive Year
Dec 11, 2025 18:00 HKT
京東工業即將登陸港股:萬億賽道的長期領跑者
Dec 11, 2025 16:24 HKT
<< Previous Next >>
 Releases By Language
All
English
Indonesian
Japanese
Korean
Thai
Trad. Chinese
Simp. Chinese
Vietnamese
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: